Using her insight gained at the U.S. Department of Health and Human Services, Office of the General Counsel (HHS-OGC), Dawn Perez-Slavinski advises healthcare clients on complex regulatory issues implicated by day-to-day operations, healthcare transactions, and internal and government investigations. Her practice focuses on evaluating and mitigating legal risks and exposure that arise in the context of healthcare program participation, billing, and reimbursement requirements. As part of this work, Dawn also helps clients comply with government reporting and repayment obligations. In addition, Dawn assists clients in navigating emerging areas, such as regulatory waivers issued in the context of COVID-19, and eligibility and permitted uses for HHS’s Relief Fund payments.
Prior to joining Bass, Berry & Sims, Dawn was a program integrity attorney in the CMS Division of HHS-OGC. In this capacity, she helped CMS evaluate disclosures made under the Self-Referral Disclosure Protocol, review the legality of CMS regulations and guidance, and create safeguards to protect the financial integrity of the Medicare and Medicaid programs. In addition, Dawn counseled CMS’s Innovation Center on how to create financial protections and flexibilities for various alternative payment models, including waivers of federal fraud and abuse laws. Dawn also provided critical support to the HHS Office of Inspector General and the U.S. Department of Justice, and represented CMS, in False Claims Act investigations and litigation.
Prior to her experience at HHS-OGC, Dawn was an associate in the healthcare and corporate practice groups of a Virginia-based law firm. In this role, Dawn focused on administrative appeals of Medicare and Medicaid overpayment determinations, and HIPAA, managed care and licensure issues.
American Health Law Association (AHLA) — Regulation, Accreditation, and Payment Practice Group Leadership Development Program (2019-2020)
Virginia State Bar
Representation of AA Medical, which provides offerings for the new and resale medical device equipment markets, in its sale to Shore Capital Partners LLC, a Chicago-based private equity firm, that is focused on microcap investments within healthcare and other industries. Terms of the transaction were not disclosed.
Representation of New Harbor Capital’s portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in its acquisition of Comprehensive Behavioral Health, a leading multidisciplinary mental health treatment provider. Terms of the transaction were not disclosed.
Representation of Addus HomeCare Corporation (NASDAQ: ADUS) in its $29.1 million acquisition of three affiliated entities: Armada Skilled Home Care of New Mexico, LLC, Armada Hospice of New Mexico, LLC and Armada Hospice of Santa Fe, LLC. This acquisition expands Addus HomeCare’s home health and hospice services in the state of New Mexico.
Representation of Brookdale Senior Living Inc. (NYSE: BKD) in its definitive agreement to sell 80 percent of Brookdale Health Care Services, the Brentwood-based company’s home health and outpatient therapy division, to HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, in an all-cash transaction for $400 million
Representation of Humana Innovation Enterprises Inc. (affiliated with Humana Inc.) in its minority joint venture investment in Summit Medical Group, East Tennessee’s largest primary care organization.
Representation of Health Enterprise Partners (HEP), a healthcare private equity firm, in its investment in Aware Recovery Care, an in-home addiction treatment provider. Terms of the transaction were not disclosed.
We represented Numotion, a provider of products and services that provide mobility, health and personal independence, in its acquisition of Wheeler’s Medical Supply, a provider of intermittent catheters and incontinence supplies based in Jacksonville, Florida. Terms of the transaction were not disclosed.
Advised research institutions and laboratory companies on Medicare billing for clinical trials, observational studies and other research
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million
Best Lawyers: Ones To Watch — Health Care Law (2021-2023)